TAMPEREEN AMMATTIKORKEAKOULU OY

Their core work

Tampere University of Applied Sciences (TAMK) is a Finnish polytechnic institution that contributes practical field implementation capacity to EU research consortia, bridging academic research and real-world regional application. In health, they have worked on personalized cardiovascular prevention — translating biomarker research and lifestyle interventions into practical secondary prevention programmes. In urban sustainability, they have contributed to food system transformation through living lab methodology, helping cities redesign local food policy and supply chains. Their applied science mandate makes them most useful to consortia that need regional anchoring, stakeholder facilitation, and on-the-ground implementation rather than laboratory research.

What they specialise in

How they've shifted over time

Their earliest H2020 engagement was in personalised health prevention — specifically coronary heart disease, secondary prevention protocols, and biomarker-driven lifestyle interventions — though in a third-party (subcontracted) capacity. By 2021, their substantive, funded participation shifted entirely to urban food systems: living labs, city-level food planning, and knowledge-sharing between urban and rural actors. The two areas share a common thread of translating research into community-level behaviour change, but the sectoral pivot from clinical health to urban food governance is clear and significant.

TAMK is moving toward city-level sustainability challenges — urban food planning, living labs, and food policy — suggesting they are building capacity as a regional implementation partner for urban innovation consortia rather than in clinical or biomedical research.

How they like to work

TAMK has never coordinated an H2020 project; they join as participant or third party, consistently contributing specialist applied capacity within larger consortia. Their presence in projects with 67 unique partners across 18 countries indicates they are comfortable operating in well-networked, multi-country Innovation Actions. As a third party in CoroPrevention, they likely provided regional field access or professional training capacity under subcontract rather than leading a work package.

TAMK has reached 67 unique consortium partners across 18 countries through just two projects, reflecting their participation in large Innovation Actions with broad European footprints. There is no evidence of repeated partnerships, suggesting their network is wide but not yet deep.

What sets them apart

Unlike research universities, TAMK is an applied science institution whose value lies in regional implementation, professional education infrastructure, and city/industry connections in the Tampere region — one of Finland's leading technology and urban development hubs. They are not a source of original scientific discovery but an effective bridge between research consortia and real-world deployment in Northern Europe. For consortium builders needing a Finnish regional partner with community and municipal reach, TAMK offers a practical complement to more research-intensive members.

Highlights from their portfolio

• FUSILLI
  TAMK's only directly funded H2020 project (EUR 331,000), running 2021–2024, placing them inside a multi-city Innovation Action redesigning urban food systems across Europe through living labs — their most substantive and recent EU engagement.
• CoroPrevention
  A long-horizon project (2020–2026) in personalised cardiovascular prevention where TAMK contributed as a third party, showing early-stage ties to the digital health and preventive medicine community even outside formal partnership roles.